Skip to content
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company
Companies

ISE Chemicals

伊勢化学工業

4107 · TSE · Chemicals · 1 article

Financials Consolidated

Revenue¥39.3bn+17.9% year on yearConsolidated · FY12/25

Ordinary profit¥9.25bn+24.4% year on yearConsolidated · FY12/25

Net profit¥6.50bn+28.1% year on yearConsolidated · FY12/25

Dividend per share¥390.00FY12/25

Performance over time

Revenue
¥20.4bnFY12/21
¥25.6bnFY12/22
¥26.4bnFY12/23
¥33.3bnFY12/24
¥39.3bnFY12/25
Ordinary profit
¥2.69bnFY12/21
¥3.66bnFY12/22
¥5.12bnFY12/23
¥7.44bnFY12/24
¥9.25bnFY12/25
Net profit (attributable)
¥1.77bnFY12/21
¥2.56bnFY12/22
¥3.67bnFY12/23
¥5.07bnFY12/24
¥6.50bnFY12/25
Op. cash flow
¥3.29bnFY12/21
¥2.14bnFY12/22
¥4.37bnFY12/23
¥3.46bnFY12/24
¥7.53bnFY12/25

People & pay

Employees, whole group327 peopleFY12/25

Employees, parent company (non-consolidated)299 peopleFY12/25

Average salary¥8.22mFY12/25

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history
Five-year history
Fiscal yearRevenueOrdinary profitNet profit (attributable)EPSDividendTotal assetsNet assetsOp. cash flow
FY12/25¥39.3bn+17.9% year on year¥9.25bn¥6.50bn¥127.52¥390.00¥51.0bn¥40.1bn¥7.53bn
FY12/24¥33.3bn+26.0% year on year¥7.44bn¥5.07bn¥99.52earlier report differs¥360.00¥45.3bn¥35.6bn¥3.46bn
FY12/23¥26.4bn+3.3% year on year¥5.12bn¥3.67bn¥720.48¥270.00¥40.1bn¥31.9bn¥4.37bn
FY12/22¥25.6bn+25.6% year on year¥3.66bn¥2.56bn¥502.73¥185.00¥36.1bn¥29.2bn¥2.14bn
FY12/21¥20.4bn¥2.69bn¥1.77bn¥347.94¥120.00¥33.4bn¥27.1bn¥3.29bn

Earlier report differs: an earlier annual report stated the same period's figure more than 5% differently; the latest report's figure is shown.

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100XT8H · Japan GAAP. Each figure's years come from one report's five-year summary.

Latest coverage

TSE:4107

Tokyo Brief coverage

All articles loaded · 1 shown

Cross-holdings

Strategic shareholdings and sales, by fiscal year.

1 fiscal year · data through

Balance-sheet value is the reporting company's own listed holdings (its largest holding subsidiary's where marked), carried at market value; the percentage divides it by consolidated net assets in the same annual report.

Cross-holdings
Fiscal year endHoldings (issuers)Balance-sheet value% of consolidated net assetsIssues cutSale proceedsFiling
31 Dec 2020No listed strategic holdings reported————Filed 

Fund positioning

Current holdings disclosed by tracked funds.

18 funds · data through

Held by 18 tracked funds; largest weight 0.14%. Holdings as of 31 Jul 2026–20 Nov 2026.

Show 8 more funds (18 total)